4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-020162
EVP, Growth Markets Commercial sold 320 shares at $16.64 ($5,326)
- EVP, Growth Markets Commercial acquired 872 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nazzi Gianfranco · EVP, Growth Markets Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-17 | Exercise or conversion : show line 1 in the form | +872 | 9,322.36 | D | ||
| 2019-03-18 | Sale : show line 2 in the form | −320 | $16.64 | $5,326 | 9,002.36 | D |
| Open-market sales · 320 sh · avg $16.64 · $5,326 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-17 | Exercise or conversion : show line 3 in the form Restricted Share Units | −872 | 874 | D |
Loading xslF345X03/doc4.xml…